CBAIX
Price
$48.19
Change
+$0.19 (+0.40%)
Updated
Jul 25 closing price
Net Assets
1.42B
RLEFX
Price
$37.17
Change
+$0.07 (+0.19%)
Updated
Jul 25 closing price
Net Assets
253.86B
Interact to see
Advertisement

CBAIX vs RLEFX

Header iconCBAIX vs RLEFX Comparison
Open Charts CBAIX vs RLEFXBanner chart's image
Calvert Balanced I
Price$48.19
Change+$0.19 (+0.40%)
VolumeN/A
Net Assets1.42B
American Funds American Balanced R5E
Price$37.17
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets253.86B
CBAIX vs RLEFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CBAIX vs. RLEFX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBAIX is a Buy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 254B vs. CBAIX (1.42B). RLEFX pays higher dividends than CBAIX: RLEFX (2.01) vs CBAIX (1.51). CBAIX was incepted earlier than RLEFX: CBAIX (26 years) vs RLEFX (10 years). CBAIX (0.66) is less costly to investors than RLEFX (0.39). CBAIX is a more actively managed with annual turnover of: 153.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than CBAIX: RLEFX (250) vs CBAIX (1000000). RLEFX annual gain was more profitable for investors over the last year : 10.46 vs. CBAIX (9.75). CBAIX (40.83) and RLEFX (40.77) have equivalent 5 years return.
CBAIXRLEFXCBAIX / RLEFX
Total Expense Ratio0.660.39169%
Annual Report Gross Expense Ratio0.660.39169%
Fund Existence26 years10 years-
Gain YTD6.1509.13367%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B254B1%
Annual Yield % from dividends1.512.0175%
Returns for 1 year9.7510.4693%
Returns for 3 years39.0035.42110%
Returns for 5 years40.8340.77100%
Returns for 10 years63.21N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MERC3.960.15
+3.94%
Mercer International
UEC8.910.14
+1.60%
Uranium Energy Corp
NMR6.790.04
+0.59%
Nomura Holdings
BGLC4.900.02
+0.41%
Bionexus Gene Lab Corp
SOL1.91-0.02
-1.04%
Emeren Group Ltd